Terlipressin in control of acute hemobilia during therapeutic ERCP in patient with portal biliopathy

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 19, Issue 5, 2009, Pages

  Tyagi, Pankaj ^a   Sachdeva, Sanjeev ^a   Agarwal, Anil K ^a   Puri, Amerender S ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

ERCP; Hemobilia; Portal biliopathy

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; TERLIPRESSIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BALLOON; BILIARY TRACT DISEASE; BILIRUBIN BLOOD LEVEL; CASE REPORT; COMMON BILE DUCT STONE; DRUG EFFICACY; DRUG INFUSION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; HEMOBILIA; HUMAN; MORTALITY; OBSTRUCTIVE JAUNDICE; PAIN; PORTAL BILIOPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; BILE DUCTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HEMOBILIA; HUMANS; JAUNDICE, OBSTRUCTIVE; LYPRESSIN; MALE; MIDDLE AGED; PORTAL VEIN; RETROSPECTIVE STUDIES; SPHINCTEROTOMY, TRANSHEPATIC; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 74949089107     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e3181ba43f0     Document Type: Article

References (17)

1. Malkan GH, Bhatia SJ, Bashir K, et al. Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications. Gastrointest Endosc. 1999;49:344-348.
2. Dilawari JB, Chawla YK. Pseudosclerosing cholangitis in extrahepatic portal venous obstruction. Gut. 1992;33:272-276.
3. Khuroo MS, Yattoo GN, Zargar SA, et al. Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology. 1993;17:807-813.
4. Bhatia V, Jain AK, Sarin SK. Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy. Gastrointest Endosc. 1995;42:178-181.
5. Thervet L, Faulques B, Pissas A, et al. Endoscopic management of obstructive jaundice due to portal cavemoma. Endoscopy. 1993;25:423-425.
6. Tighe M, Jacobson I. Bleeding from bile duct varices: an unexpected hazard during therapeutic ERCP. Gastrointest Endosc. 1996;43:250-253.
7. Mutignani M, Shah SK, Bruni A, et al. Endoscopic treatment of extrahepatic bile duct strictures in patients with portal biliopathy carries a high risk of haemobilia: report of 3 cases. Dig Liver Dis. 2002;34:587-591.
8. Khare R, Sikora SS, Srikanth G, et al. Extrahepatic portal venous obstruction and obstructive jaundice: approach to management. J Gastroenterol Hepatol. 2005;20:56-61.
9. Chaudhary A, Dhar P, Sachdev A, et al. Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg. 1998;85:326-329.
10. Ito T, Segawa T, Kanematsu T. Successful endoscopic injection sclerotherapy for bleeding from bile duct varices. Surg Today. 1997;27:174-176.
11. Gorgul A, Kayhan B, Dogan I, et al. Disappearance of the pseudo-cholangiocarcinoma sign after TIPSS. Am J Gastroenterol. 1996;91:150-154.
12. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167-176.
13. Hymes JL, Haicken BN, Schein CJ. Varices of the common bile duct as surgical hazards. Am Surg. 1977;43:687-688
14. Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther. 2003;17:53-64.
15. Walker BR, Childs ME, Adams EM. Direct cardiac effects of vasopressin: role of V1-and V2-vasopressinergic receptors. Am J Physiol. 1988;255:H261-H265.
16. Møller S, Hansen EF, Becker U, et al. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000;20:51-59.
17. Krag A, Borup T, Møller S, et al. Efficacy and Safety of Terlipressin in cirrhotic patients with variceal bleedingor hepatorenal syndrome. Adv Ther. 2008;25:1105-1140.